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Abstract
Traditional medicines can serve as the source of potential new drug candidates 
and initial research focuses on the isolation of bioactive lead compounds. Medicinal 
plants have a combination of secondary metabolites that are naturally occurred by 
giving different therapeutic benefits. Phytoconstituents have been recognized as an 
important role in the drug discovery process moreover the other sources. Presently, 
over hundred natural product-derived pharmaceuticals are being used in modern 
medicine. Plants and their secondary metabolites, with activity against targets 
associated with the viral infections could provide valuable leads for the develop-
ment into drugs for the novel antiviral drugs. Some of them play as important tools 
in the immune system exhibiting antiviral potentials. The objective of this review 
is to conduct information regarding the potential of traditional medicines to which 
have shown antiviral activity against SARS-CoV-2 infection.
Keywords: Antiviral, traditional medicine, medicinal plants, phytoconstituents, 
SARS-CoV-2
1. Introduction
Medicinal plants produce various secondary metabolites in their normal meta-
bolic pathways and these metabolites play an important role for providing the 
activities of different therapeutic benefits. Medicinal plants have been considered 
for many years as an essential source of drugs such as morphine, digoxine, quinine, 
taxol, galantamine, artemisinine etc. for the treatment of several diseases and these 
natural products are still popular main stream stage for researchers to discovery of 
novel bioactive compounds with recent advancement in science and technology. 
Furthermore, FDA-approved antiviral drugs (famciclovir, ganciclovir, sorivudine, 
zidovudine, didanosine, zalcitabine, stavudine and ivermectin) are originally 
modeled on a natural product parent. The potential utilization of plant extracts 
and their secondary metabolites to combat the development of antiviral agents is 
considered to be one of the most important approaches toward effective therapy for 
viral infections by inhibiting the replication cycle of various DNA and RNA viruses. 
Among the viral infections, Human Immunodeficiency Virus type 1 (HIV-1) and 
2 (HIV-2) as genetic variabilities that causes Acquired Immunodeficiency Syndrome 
(AIDS) which is one of the most dangerous infectious disease all over the world and 
has led to the death of many people. The anti-HIV potential of the 717 plant spe-
cies belonging to 151 families were summarized for 206 HIV-reverse transcription 
(HIV-RT), 254 HIV-protease (HIV-PR) and 43 species as HIV-integrase (HIV-IN); 
among them Calendula officinalis, Justicia gendarussa and Sceletium tortuosum might 
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be useful potential sources for new lead compounds in the development of new can-
didates with anti-HIV properties of therapeutic interest reported by Salehi et al. [1]. 
16 ethanolic extracts of Turkish medicinal plants were evaluated for their antiviral 
activities against Herpes Simplex Virus (HSV) and Sindbis virus (SINV); according 
to results, the extracts of Galanthus elwesii and Rheum ribes showed the most potent 
anti-HSV activities as well as Galanthus elwesii and Leucojum aestivum were found 
to be the most potent anti-SINV [2]. Moreover, 14 herbal products with confirmed 
clinical safety features were attractive starting material for the identification of 
new antiviral activities and their identified compounds for the eradication of viral 
diseases were also reported [3]. Severe Acute Respiratory Syndrome Coronavirus 2 
(SARS-CoV-2), Influenza A Virus (IAV), and Noro Virus (NV) are highly pathogens 
that affected the health of the worldwide community. SARS-CoV-2 is an enveloped 
RNA virus (genus Betacoronavirus, subgenus Sarbecovirus) that was originated in 
December 2019 in patients with infectious pneumonia in Wuhan, China. Despite 
of intense efforts relevant to experimental and clinical studies since the start of 
the COVID-19 pandemic, no disease-specific drug is available, yet. Several treat-
ment strategies including already known antiviral drugs, interpherons, interleukin 
inhibitors, and other drugs acting through different mechanims are being imple-
mented in COVID-19 patients. Moreover, the traditional medicines can serve as the 
source of potential new drug candidates and initial research focuses on the isolation 
of antiviral lead compounds. This review particularly presents a survey of recent 
studies on traditional medicines, medicinal plants and phytoconstituents that have 
indicated antiviral activity for SARS-CoV-2 infection.
2. Traditional medicines
Traditional medicine is being frequently used all over the world. Treatment 
with traditional medicine is still esteemed highly, particularly by those who have 
no access to modern health-care. Traditional medicine is to be understood as the 
total of the knowledge, practices based on theories and experiences indigenous to 
different cultures used to maintain and improve health, to prevent and diagnose 
illnesses. Traditional medicine can be included in medical systems and folk medi-
cine along with health knowledge. The numbers of medicinal plants from various 
medical systems like Ayurveda, Siddha, Unani, Traditional Chinese Medicine, 
Kampo, etc. could be taken into consideration as an inspiring source for bioactive 
phytochemicals as drug designing as well as nutraceuticals and functional foods 
for wellness. Based on Lipinski factors and lower binding energies, numbers of 
compounds from medicinal plants were analyzed for their pharmacological and 
biological characteristics. Some selected bioactives were found to have lower 
toxicity with a higher gastrointestinal absorption rate and potent anti-inflamma-
tory and anti-viral activities against targets of COVID-19 which is an infectious 
pandemic caused by the SARS-CoV-2 virus. The critical target components of 
SARS-CoV-2 are the Spike protein (S-protein) and the Main protease (Mpro). 
Mpro is required for the maturation of the various polyproteins involved in 
replication and transcription. S-protein helps the SARS-CoV-2 to enter the host 
cells through the Angiotensin-Converting Enzyme 2 (ACE-2). Since ACE-2 is 
required for the binding of SARS-CoV-2 on the host cells, ACE-2 inhibitors and 
blockers have got wider attention, in addition to S-protein and Mpro modulators 
as potential therapeutics for COVID-19. So far, no specific drugs have shown 
promising therapeutic potential against COVID-19. Therfeore, several studies 
were undertaken to evaluate the therapeutic potential of traditional medicinal 
plants against COVID-19.
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2.1 Traditional Chinese medicine
Based on the frequency of appearance of each medicinal herb and their cor-
responding pharmacological activities from Traditional Chinese Medicines 
(TCM), one of the TCM formula was reconstructed with the potential of treating 
COVID-19 infection. This TCM formula contains herbs with evidenced antiviral 
activity along with reducing fever, removing dampness, expelling phlegm, and 
arresting coughing. It includes Bupleurum chinense, Ramulus cinnamomi, Scutellaria 
baicalensis, Glycyrrhiza glabra, Atractylodes macrocephala, Rhizoma Zingiberis, 
Agastache rugosa, Stephania tetrandra root, Polygonum cuspidatum, Rheum pal-
matum, Tangerine Peel, Semen Armeniacae Amarum and Ophiopogon japonicus 
root. These herbs have the effect of eliminating dampness, for relieving cough 
and lung symptoms. In addition, in modern pharmacology, Rheum palmatum and 
Polygonum cuspidatum have significant antiviral effects due to their rich emodin 
content. Full prescription of 12 drugs are evaluated for the clinical treatment of 
COVID-19 [4]. On the other hand, a medicinal plant library containing 32,297 
potential antiviral traditional Chinese medicinal plants compounds were analyzed 
the 3-Chymotrypsin-Like protease (3CLpro) sequence which plays a critical role in 
the replication of virus particles and unlike structural/accessory protein-encoding 
genes constructed its 3D homology model. These analyses revealed that the top 
nine hits might serve as potential anti-SARS-CoV-2 lead molecules for further 
optimisation and drug development process to combat COVID-19. The proteolytic 
processing is mediated by Papain-Like protease (PLpro) and 3CLpro. The 3CLpro 
cleaves the polyprotein at 11 distinct sites to generate various non-structural 
proteins that are important for viral replication [5].
In Asian countries, Saxifraga species (Saxifragaceae) are used as medicinal herbs 
for treatment of various types of disorders. With respect to antiviral activities, 
Saxifraga melanocentra inhibited the activity of hepatitis C virus serine protease. 
The virucidal activity of pyrogallol compounds obtained from Saxifraga spinulosa 
have also suggested against SARS-CoV-2, Influenza A (IAV), as well as Feline Calici 
Virus (FCV) and Murine Noro Virus (MNV) [6].
2.2 Traditional Persian medicines
In Iran, some medicinal plants have great potential value for treatment of 
COVID-19 based on the therapeutic approaches of Traditional Persian Medicine 
(TPM) is one of the most ancient medical doctrines mostly known as “wi”, several 
of which have also been confirmed by pharmacological studies in modern medicine. 
Among them, Amla (Phyllanthus emblica L.), Chicory (Cichorium intybus L.), Clove 
[Syzygium aromaticum (L.) Merr. and L.M.Perry], Damask Rose (Rosa × damascena 
Herrm.), Fenugreek (Trigonella foenum-graecum L.), Galangal (Alpinia galanga (L.) 
Willd., A. officinarum Hance), Garlic (Allium sativum L.), Grape and Raisin (Vitis 
vinifera L.), Licorice (Glycyrrhiza glabra L., G. uralensis Fisch.), Rhubarb (Rheum 
palmatum L., R. officinale Baill.) and Saffron (Crocus sativus L.) were determined as 
promising plant species. However, preclinical mechanistic studies as well as clinical 
trials are necessary to confirm the safety and efficacy of these plants for the man-
agement of SARS-CoV-2 infection [7].
2.3 Ayurveda
For nearly 5000 years Ayurveda, an ancient Indian medicine method, has 
been practiced in India, relying heavily on plants to formulate it. Ayurvedic 
herbal supplements and immunity boosters showing the way to a broad-spectrum 
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antiviral drug that is the need of the hour. Antiviral properties of Glycyrrhiza 
glabra, Andrographis paniculata, Phyllanthus spp., Zingiber officinale, Withania 
somnifera, and Curcuma longa have been reported [8]. Whereas, Tinospora cordi-
folia and Emblica officinalis have the properties to enhance immunity. It has been 
shown that Coptidis rhizome, Meliae cortex, Sanguisorbae radix, Cimicifuga rhizome, 
and Phellodendron cortex exhibit anti-coronavirus activity. Sophorae radix, Torilis 
fructus, and Acanthopanacis cortex decreased intracellular viral RNA levels with cor-
responding viral protein decreases [9]. The antiviral activity of some phytoconstit-
uents present in traditional medicinal plants from Ayurveda were also investigated 
against spike glycoprotein of SARS-COV-2 as well as its host ACE-2 receptor. Some 
parameters like drug-likeness, pharmacokinetics, and toxicity were also determined 
to ensure the safety and efficacy of active constituents. Based on the findings ama-
rogentin, eufoliatorin, α-amyrin, caesalpinins, kutkin, β-sitosterol, and belladon-
nine were found the top ranked molecules have the highest affinity toward both the 
spike glycoprotein and ACE-2 [10]. Further, fourthy-one plant-derived compounds 
from Indian medicinal plants were screened for their inhibitory effect on Main pro-
tease (Mpro) of SARS-CoV-2 using the molecular docking approach. Among them 
amentoflavone, lectin, glycyrrhizic acid, hypericin and torvoside H exhibited high 
binding energy. Amentoflavone isolated from Torreya nucifera showed the highest 
binding energy of 10.0 kcal/mol with the SARS-CoV-2 Mpro [11]. Furthermore, 
free energy calculations on these compounds performed by using the molecular 
docking procedure. The results suggested that amentaflavone, hypericin, and 
Torvoside H respectively complexed with SARS-CoV-2 Mpro show better binding 
with stabilizing interactions and provided valuable information in developing new, 
novel and natural anti-viral drugs for COVID-19 [9]. In addition, taraxerol isolated 
from Clerodendrum species has shown potential antiviral activities with desirable 
pharmacological features [12]. Withanolide A active constituent of ayurvedic 
herb from Withania somnifera has shown promising antiinfluenza properties by 
targeting neuraminidase of H1N1 Influenza as well as the highest binding affinity 
with S-protein and ACE-2 receptor [13]. AYUSH Ministry of Health, India, has 
recommended the use of the aqueous extract of Withania somnifera as a preventive 
and prophylactic for treating COVID-19 infection. Withametelin isolated from 
Datura innoxia plant, has shown a better binding affinity against Mpro, S-protein 
and ACE-2. However, the pharmacological analysis revealed its toxicity to health. 
Other compound known as Daturaolone also isolated from Datura innoxia, has 
shown lower toxicity and potent antiviral and anti-inflammatory activities. These 
compounds can be further developed and assessed as phytoformulations against 
SARS-CoV-2 infection [8].
2.4 Siddha medicine
During molecular docking and simulation analysis for the prevention and cure of 
COVID-19 infection on some phytoconstituents of Siddha medicine were determined 
as potential candidates. Among them orientin, bis-andrographolide, cucurbitacin B, 
cucurbitacin E, isocucurbitacin B, vitexin, berberine, bryonolic acid, piperine and 
magnoflorine were identified as potential lead molecules that have been shown to 
possess the ability to interact with the components that block the viral replication 
in SARS-CoV-2. Moreover, the immune-enhancing properties of these compounds 
without any adverse side effects could provide natural immune power to resist 
COVID-19 infections [14]. Several plants have been found to act on the ACE-2 
receptor, which could become promising antiviral agents and can help in combatting 
COVID-19 pandemic. Rheum palmatum, Polygonum multiflorum, Cerasus avium, 
Alcea digitata, Rubia tinctorum, Citrus aurantium, Berberis integerrima, Peganum 
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harmala and Allium sativum have the potential to act on the ACE-2 receptor and are 
well-known for blocking the transmission or entry of Coronoviruses. These plants 
can possibly be used for the combinational therapeutic management of COVID-19 by 
inhibiting various protein targets of SARS-CoV-2 (Table 1) [15].
Traditional 
medicines














































































































































































Alizarine, Aloe-Emodin, Amaranthin, Anthrarufin, Calceolarioside B, 
Curcumin, Dantron, Emodin, Harman, Harmalol, Hypericin, Licoleafol, 
Lycorine, Methyl rosmarinate, Mycophenolate Mofetil, Myricetin, 
Myricitrin, Ouabain, Resveratrol, Scutellarein, Silvestrol, Tylophorine, 
Vasicine, Vasicinone, 5,7,3′,4′-tetrahydroxy-2′-(3,3-dimethylallyl) 




The list of traditional medicines for antiviral activities.
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2.5 Thai traditional medicine
Among 122 Thai traditional medicines, Boesenbergia rotunda extract and its 
compound, known as panduratin A exhibited the potent anti-SARS-CoV-2 activity 
by using the high-content imaging system coupled with the plaque reduction assay. 
Treatment with Boesenbergia rotunda extract and panduratin A after viral infection 
drastically suppressed SARS-CoV-2 infectivity in Vero E6 cells with IC50 of 3.62 μg/
mL (CC50 = 28.06 μg/mL) and 0.81 μΜ (CC50 = 14.71 μM), respectively. Also, the 
treatment of panduratin A at the pre-entry phase inhibited SARS-CoV-2 infec-
tion with IC50 of 5.30 μM (CC50 = 43.47 μM). Therefore, Panduratin A exerted the 
inhibitory effect against SARSCoV-2 infection at both pre-entry and post-infection 
phases as the novel natural candidate [16].
2.6 African traditional medicine
Fifteen African ethnomedicinal herbs (Abrus precatorius L. Gaertn, Achyranthes 
aspera L., Allium sativum L., Annona muricata L., Artemisia afra Jacq. ex Willd, 
Azadirachta indica A. Juss., Cryptolepis sanguinolenta (Lindl.) Schltr., Curcuma 
longa L., Euphorbia hirta L., Garcinia kola Heckel, Glycyrrhiza glabra L., Moringa 
oleifera Lam., Nigella sativa L., Psidium guajava L., Zingiber officinale Roscoe) used 
in African traditional medicine from different countries in Africa were investi-
gated in the prevention, treatment and management of COVID-19 infection [17]. 
From them, Glycyrrhiza glabra was reported to be successful inhibitor for SARS-
CoV replication and was recommended for the management COVID-19. Due to the 
complex nature of SARS-CoV-2 and clinical presentation of COVID-19 disease, 
combining two or more extracts with various pharmacological activity from these 
herbs in a standard dosage form such as capsule, tablets, syrups, and injections 
is necessary in the management of the disease. This combination would improve 
adherence but care must be taken to ensure that all ingredients in the formula-
0tion are compatible otherwise it may lead to therapeutic failure or toxicity. These 
findings will serve as a source of information for future research in the selection of 
herbs which could be used in the management of COVID-19 [17].
2.6.1 African medicinal plants
Sixty-two alkaloids and hundred terpenoids isolated from some African 
medicinal plants were docked to the 3-Chymotrypsin-Like protease (3CLpro) 
controled coronavirus replication as a promising drug target for combating the 
coronavirus infection. The twenty alkaloids and terpenoids with high bind-
ing affinities to the SARS-CoV-2 3CLpro were further docked to the 3CLpro 
of SARS-CoV by comparing with the reference inhibitors (Lopinavir and 
Ritonavir). From them, 10-hydroxyusambarensine, cryptoquindoline, 6-oxoisoi-
guesterin and 22-hydroxyhopan-3-one showed potent activity against SARS-
CoV-2 3CLpro [31].
2.6.2 Nigerian medicinal plants
Fifty Nigerian medicinal plants and their 9 phytoconstituents were inves-
tigated against symptoms related to COVID-19. Their specific therapeutic 
actions are administered to combat the key players in the pathogenesis of the 
disease [32].
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2.6.3 Moroccan medicinal plants
The molecular docking studies on sixtyseven phytoconstituents from Moroccan 
medicinal plants were evaluated for their in vitro and in vivo antiviral activity 
against SARS-COV-2 Main protease before clinical trial. The results of molecu-
lar docking studies showed that three compounds (crocin, digitoxigenin, and 
β-eudesmol) were proposed as inhibitors against the coronavirus based on the 
energy types of interaction between these compounds and studied protein [33].
2.6.4 South African medicinal plants
Twentynine phytoconstituents isolated from commonly used South African 
traditional medicinal plants were examined against SARS-CoV-2 using molecular 
docking and molecular dynamics. Molecular docking identified arabic acid from 
Acacia senegal and L-canavanine found in Sutherlandia frutescens were determined 
as a potential inhibitor 3C-Like main protease (3CLpro) of SARS-CoV-2. Similarly, 
hypoxoside isolated from Hypoxis hemerocallidea and uzarin from Xysmalobium 
undulatum were also identified as a potential inhibitor of SARS-CoV-2 receptor 
binding domain and SARS-CoV-2 RNA-dependent polymerase (SARS-CoV-2 
RdRp). In addition, these compounds exhibited favorable binding orientations 
characterized by strong molecular interactions within respective inhibitors binding 
pockets of the target enzymes [34].
2.7 Traditional medicinal plants of South American countries
Uncaria tomentosa (cat’s claw) is traditionally used medicinal plant in South 
American countries. Twentysix phytoconstituents of Uncaria tomentosa were docked 
on the binding interface of the ACE-2 and SARS-CoV-2 spike protein of novel corona 
virus. From these compounds namely Proanthocyanidin C1, 3-isodihydrocadam-
bine, Uncarine F and Uncaric acid had a good predicted binding affinity for inter-
face of the ACE-2 as compared to the sulfated Heparin OctaSaccharide (HepOS). 
Likewise, 3-dihydrocadambine, Proanthocyanidin B4, Proanthocyanidin B2 and 
Proanthocyanidin C1 had the highest docking score on SARS-CoV-2 spike glyco-
protein in their open state. Virtual prediction ADME revealed that Speciophylline, 
Uncarine F and Uncaric acid presented values of drug ability according to Lipinski 
rule, demonstrating their potential bioavailability as likely orally active antiviral. 
Uncaria tomentosa can be performed as an herbal supplement with the safety and 
efficacy parameters at both preclinical and clinical stages to evaluate its effectiveness 
in the treatment of novel coronavirus disease (COVID-19) [18].
Thirty-nine herbal medicinal plants known in the America and Europe for the 
management of respiratory conditions, mainly regarding the symptoms cough, pain 
and fever were studied for their therapeutic potential alongwith the limitations for 
their use and possible risks. For five out of the 39 herbal drugs a positive benefit/risk 
assessment was determined. The level of evidence for Althaea officinalis, Commiphora 
molmol, Glycyrrhiza glabra, Hedera helix and Sambucus nigra are suggested a potential 
clinical use as adjuvants in the treatment of early/mild cases of COVID-19. Another 
twelve herbal medicines were classified as promising plant species [19].
3. Various phytoconstituents
Various phytoconstituents occured in living organisms in a high structural 
diversity have antiviral activities by inhibiting different stages in the replication 
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of various viruses. Their different antiviral mechanisms like virus adsorption, 
virus-cell fusion, reverse transcription, protease and integrase inhibition have 
been reported in recent studies [20, 21]. Lycorine, hypericin, emodin, tylophorine, 
ouabain, mycophenolate mofetil, silvestrol, myricetin and scutellarein were also 
reported for their inhibitory effects against SARS-CoV-2 and other human coro-
naviruses [22]. Some phytoconstituents such as myricitrin, methyl rosmarinate, 
5,7,3′,4′-tetrahydroxy-2′-(3,3-dimethylallyl) isoflavone, 3,5,7,3′,4′,5′-hexahydroxy 
flavanone-3-β-D-glucopyranoside, (2S)-eriodictyol 7-O-(6′′-O-galloyl)-β-D-
glucopyranoside, calceolarioside B, myricetin, 3-O-β-D-glucopyranoside, licoleafol, 
and amaranthin were reported as potential lead candidates to develop novel anti-
SARS-CoV-2 drugs [23].
Moreover, anthraquinone derivatives were screened on the basis of binding 
energy against N-Terminal Domain (NTD) of SARS-CoV-2. Emodin, Anthrarufin, 
Alizarine, Aloe- emodin, and Dantron showed the good binding affinity at three 
different active sites of N-Terminal Domain of SARS-CoV-2 nucleocapsid phos-
phoprotein. These compounds prevent the assembly of virus particles and stop 
the infection. They are suggested as potential drugs for COVID-19 treatment [24]. 
From secondary metabolites, curcumin as the main constituent of Curcuma longa L. 
(turmeric), is the reputed compound displaying remarkable biological activities for 
human health. It has been shown to have an inhibiting effect against SARS-CoV-2 
[25]. Synthesized resveratrol derivatives have been shown to suppress SARS-CoV 
replication and reduce its clinical symptoms [26]. Some beta-carboline alkaloids 
including harman, harmalol and quinazoline-type alkaloids like vasicine and 
vasicinone have showed antiviral effect against influenza virus [27].
Among the secondary metabolites, essential oils interfere with the virus envelope 
or masking viral compounds which are necessary for adsorption or entry into host 
cells. Essential oils have long been known to have antiviral properties and are being 
proposed to have activity against SARC-CoV-2 virus [28]. Owing to their lipophilic 
nature, essential oils are advocated to penetrate viral membranes easily leading to 
membrane disruption. Moreover, essential oils contain multiple active phytochemi-
cals that can act synergistically on multiple stages of viral replication and also induce 
positive efects on host respiratory system including bronchodilation and mucus 
lysis. Their antiviral properties were shown by computer-aided docking and in vitro 
studies for anti-SARC-CoV-2 [29, 30].
4. Conclusion
Plants and their secondary metabolites provide valuable leads for the development 
into drugs for the novel antiviral activities. Ivermectin is the FDA approved drug 
and inhibited the replication of SARS-CoV-2 [35]. Although there is an increase in 
the use of traditional medicine worldwide, researches in traditional medicines are 
insufficient. Assessments of the quality, safety, and efficacy of traditional medicines 
are needed to provide scientific information that regulations need. In the present 
review, antiviral activity mainly against coronaviruses of traditional medicines along 
with their phytoconstituents through the literature data relevant to their enzyme and 
receptor interactions given by different assays. Pre-clinical studies would provide deep 
insight into mechanism of actions and also drug ability of the antiviral candidates for 
the treatment of COVID-19 infection. Besides, vast range of double-blinded clinical 
studies with strict protocols is required to estimate the accurate potential of antiviral 
phytochemicals against COVID-19 with the aim of ensuring the fulfillment of interna-
tional acceptable standards. Therefore, phytoconstituents will play an important role 
and continue to support in developing potential drugs against SARS-CoV-2.
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